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Introduction
Obesity is a worldwide public health problem due to its high prevalence, the epidemic increase observed in recent decades, and the associated diseases (GBD 2015 Obesity Collaborators, 2017 Finucane, 2011; Guh, 2009 ). The World Health Organization (WHO) reports that more than 1.9 billion adults were overweight in 2014, and more than 600 million of these individuals were obese, doubling the worldwide prevalence of obesity since 1980 (Global Database on Body Mass Index, 2017). Recent projections are that global obesity prevalence will reach 18% in men and surpass 21% in women by 2025; severe obesity will exceed 6% in men and 9% in women (NCD Risk Factor Collaboration, 2016) . Finally, overweight and obesity, estimated with body mass index (BMI, calculated as weight in kilograms divided by height in meters squared), have been associated with decreased functional ability and health status and increased risk of chronic conditions in classical observational studies (Guh, 2009; Fontaine, 2003; Prospective Studies Collaboration, 2009; Stenholm, 2016) and in Mendelian randomization studies Holmes, 2014; Thrift, 2015) . Although BMI is well established as a risk factor or indicator, the direct effect of above-normal BMI on health outcomes remains controversial (Gao C. Int J Epidemiol. 2016; Mandviwala T. Curr Atheroscler Rep. 2016) . This effect could be secondary, through an influence on the development and severity of cardiovascular risk factors (CRF) such as hypertension, diabetes, and hypercholesterolemia (Bogers, 2007;  Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration, 2014; Jerant, 2012; Poirier P. Circulation. 2006 ). However, it may also occur in the absence of CRF and may be due to structural and functional changes in excess adipose tissue deposition or to underlying mechanisms that remain unknown (Global Burden of The objectives of the present study are: (1) to ascertain the association of BMI and different BMI cut-off points with 10-year cardiovascular disease (CVD) incidence and with cancer and overall mortality in a population-based cohort of more than 54,000 participants, and (2) to describe the interaction of CRF in the association between above-normal BMI values and the risk of all three outcomes.
Methods

Design and participants
We conducted a pooled analysis of anonymized individual data from 12 population cohorts in 7 Spanish regions, examined between 1992 and 2005 with similar methods;
the methodology of this cohort study has been explained elsewhere (Marrugat, 2014 cholesterol whenever triglycerides were <300 mg/dl. A previous study, in which 9 of the 12 FRESCO cohorts participated, obtained good agreement in the measurement of frozen samples from a random subset of participants, establishing that the study's laboratory measurements can be reliably pooled (Grau, 2011) . Blood pressure was determined from the average of 2 separate readings taken at least 5 min apart.
Hypertension, diabetes, hypercholesterolemia and type of treatment were self-reported by the participants in all studies. We also considered hypertension whenever an individual presented with systolic or diastolic blood pressure ≥140/90 mmHg, respectively; diabetic those participants in whom glycemia >125 mg/dl was observed at the time of baseline examination. In both cases, this condition was assigned regardless of their awareness of such disorders.
End-points
We defined three end-points for the purpose of our analysis: (1) CVD incidence: fatal or nonfatal myocardial infarction or stroke and angina pectoris;
(2) Cancer mortality and (3) Overall mortality. Multiple sources were used to identify potential CVD cases, including self-report, re-examination, and linkages to primary care registers, hospital admissions, and regional and national mortality data. All nonfatal diagnoses were verified by examining the corresponding electronic medical record.
Unstable angina during follow-up was diagnosed by the presence of angina symptoms without an abnormal increase in the cardiac enzymes or troponin and with relevant changes in serial electrocardiograms. Alternatively, with or without electrocardiographic changes, a diagnosis was made when suggestive symptoms were recorded during the event and confirmed either by a positive coronary angiography (stenosis > 70%) or by a positive stress test with or without isotopic stress gammagraphy (Marrugat, 2014) .
Vital status and causes of death during 10-year follow-up were ascertained by reviewing medical records and by linkage with the official death registry, coded according to the 10 th revision of the International Classification of Diseases (ICD).
Mortality was classified as due to CVD (ICD F01, I20-I25, I60-I69, G45), and all malignant neoplasms (ICD C00-C99, D1-D48) (Baena-Diez, 2016).
Statistical analysis
Three BMI categories were defined: (1) normal weight, BMI ≥18.5 and <25 kg/ m 2 ;
(2) overweight, BMI ≥25 and <30 kg/ m 2 ; and (3) obesity, BMI ≥30 kg/m 2 .
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Variables were summarized as mean and standard deviation (SD) and median and interquartile range (IQR) when the distribution departed from normal. Categorical variables were described as proportions. Chi-square was computed to test differences for categorical variables at baseline; analysis of variance and Kruskall-Wallis tests were used for variables that did and did not follow a normal distribution, respectively. Ten-
year differences in CVD incidence and in cancer and overall mortality by BMI categories at the end of the follow-up were computed by the Kaplan-Meier method. To assess the linear trend of variables by BMI categories, analysis of variance and chisquare tests were used. BMI categories and CRF were also summarized by outcome.
We tested the linearity of the association between continuous BMI and the risk of all three end-points considered. Adjusted Cox regression models were fitted whenever the result did not reveal a nonlinear component of the relationship.
Effect modification of the relationship between sex, CRF (age, diabetes, hypertension, smoking, total and HDL cholesterol) and BMI categories and each endpoint was tested with the -2 log-likelihood test of nested models with and without interaction terms. Two multivariable sex-stratified models were fitted for each endpoint. The first was adjusted for age and the second was further adjusted for diabetes, hypertension, smoking, total and HDL cholesterol and for the significant interactions between the CRFs and BMI category.
Sensitivity analysis was conducted using standard BMI categories: (1) normal weight, BMI ≥18.5 and <27 kg/m2, or BMI ≥25 and <27 kg/ m 2 with no further CRF;
(2) overweight, BMI ≥25 and <27 kg/ m 2 with at least one additional CRF, or BMI ≥27 and <30 kg/ m 2 ; and (3) obesity, BMI ≥30 kg/m 2 . Additionally, we conducted a competing risk analysis (Fine & Gray regression) considering death due to CVD and
cancer. Finally, we reanalyzed the data after excluding angina from the definition of fatal and non-fatal CVD.
All calculations were made with R statistical package (R Foundation for Statistical
Computing, Vienna, Austria; version 3.3.2).
Results
The FRESCO cohort included 54,446 individuals with valid BMI measurements, of which 46.5% presented with overweight and 27.8% with obesity. Figure 1 shows the end-point distribution in all three BMI categories over the 10-year median follow-up (interquartile range 8.8-10).
Cardiovascular risk profile according to BMI categories and to end-points
Individuals with overweight or obesity were significantly older, less likely to smoke, and had higher systolic and diastolic blood pressure and total and LDL cholesterol, triglycerides and glycemia values, compared with normal-weight individuals, and more often presented with hypertension and diabetes. In the highest BMI categories, significantly higher crude rates of 10-year fatal and nonfatal CVD incidence, cancer mortality, and overall mortality were observed in women, but only CVD in men (Table 1) .
Individuals who presented with an outcome in the follow-up were, in general, older, less likely to smoke, and had higher systolic and glycemia values, compared with those who do not present, and more often presented with hypertension and diabetes (Supplementary Table 2 ).
Risk of adverse health outcomes by BMI values
The age-adjusted association between BMI, as a continuous variable, and the risk of all three end-points showed a significant linear increasing trend for CVD incidence in both sexes. On the contrary, BMI significantly decreased the risk of cancer death and showed a U-shaped curve for overall mortality in men (Fig. 2 ).
An analysis by BMI categories suggested the CRF that had a modification effect for all three end-points. Multivariable models were adjusted for these interactions.
Risk of cardiovascular disease and death, by BMI category
We found a significant effect modification of the relationship between sex, CRF After adjustment for the interaction with hypertension, a significant linear association was observed between overall mortality risk and BMI category in men; in women, the adjusted hazard ratio was marginally significant [1.35 (0.96-1.89)] (Tables   3 and 4 ). Figure 3 describes the effect of the significant interactions on every outcome considered.
Sensitivity analysis
All sensitivity analyses yielded results similar to the primary analysis. On the one hand, Supplementary Tables 3-6 show the cardiovascular risk profile and the adverse health outcomes distribution according to a second BMI stratification, which considers the prevalence of CRF. Supplementary Table 7 shows the competing risks (Fine & Gray regression) of cause-specific deaths (CVD and cancer). Finally, the sensitivity analysis using a CVD end-point excluding angina is shown in Supplementary Table 8 .
Discussion
Above-normal BMI has been associated with disability and premature mortality. In the present study, obesity increased the risk of fatal and non-fatal CVD events, cancer death, and overall mortality. Aging, hypertension, hypercholesterolemia, and diabetes may have a role as effect modifiers in these relationships, although the effect was confusing in individuals with those CRF. In individuals with no effect modification, above-normal BMI may act as an independent risk factor that follows a dose-response pattern, suggesting that there is no healthy pattern of increased weight (Kramer, 2013; Borrell, 2014) . This observation may reflect, to some extent, the role of obesity as an effect mediator between CRF and the development of adverse health outcomes (i.e., serving as a risk marker) (Mandviwala, 2016) .
BMI as a risk factor for cardiovascular disease
In the age-adjusted analysis, BMI presents a clear relationship with fatal and nonfatal CVD. The role of obesity as an independent risk factor or a risk marker has long been discussed (Mandviwala, 2016) . Obesity increases the risk of coronary artery disease (the most incident CVD event) secondarily through its influence on the development and severity of comorbidities such as diabetes, hypertension, or dyslipidemia, acting in these cases as a risk marker (Poirier, 2006) . Inclusion of aging as an effect modifier showed that overweight and obesity in women were independent risk factors for fatal and non-fatal CVD. This analysis underlines the behavior of abovenormal BMI levels as an independent risk factor, in the absence of other effect modifiers.
The Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration study found that the association between adiposity and CVD was not completely explained by the three mediators studied (blood pressure, cholesterol, and glucose which traditionally have had a greater prevalence of obesity (Choudhury, 1999) . In the
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13 CRUSADE registry, obesity was the strongest risk factor linked to non-ST elevation myocardial infarction events, followed by tobacco use (Madala, 2008) . Long-term exposure to above-normal BMI leads to the development of CRF that may exceed the effect size of classical risk factors alone in calculating the risk of cardiovascular events (Yan, 2006; Twig, 2016) .
Overweight, obesity, and mortality
We observed a U-shaped curve for the association between BMI values and overall mortality risk, particularly in men. This was the only outcome in which a linear trend was not observed. This characteristic shape has also been observed in the association between BMI values and CVD and overall mortality across different regions in the world (Chen, 2013; Berrington de Gonzalez, 2010; Global BMI Mortality Collaboration, 2010; Ponce-Garcia, 2015; Padwal, 2016; Yi, 2015) . Previous analysis shows that clustering CRF (diabetes, hypertension, smoking, dyslipidemia) with obesity in statistical analysis may attenuate the effect size of the latter on health outcomes (Jerant, 2012) . The mortality risk in individuals with overweight has been discussed with quite divergent results (Chen, 2013; Berrington de Gonzalez, 2010; Global BMI Mortality Collaboration, 2010; Ponce-Garcia, 2015; Padwal, 2016; Yi, 2015; Orpana, 2010) .
Concurring with previous studies (Reeves, 2007; Renehan, 2010) , cancer mortality risk increased dramatically in women with overweight and obesity, particularly in those with total cholesterol <220 mg/dl. These results underline the sex-related differences in the role of above-normal BMI, with the effect of obesity being particularly malignant in women.
Characteristics and limitations
The FRESCO project is a pooled analysis of 12 population-based cohorts of individuals aged 35 to 79 years with two major strengths: the population representativeness and the comparativeness between all component studies that followed the MONICA standard guidelines to collect data (Tunstall-Pedoe, 1994) .
However, our study has several limitations. First, we used a single BMI measurement at baseline and did not consider any further measurements during the 10-year follow-up to monitor changes over time. Second, we did not consider other measures of obesity (e.g., abdominal circumference, waist-to-hip ratio); however, past collaborative studies including cohorts from all over the world have shown that BMI is in itself a strong -up (Wilson, 2002) . In addition, a metaanalysis has found that studies with more than 10 years of follow-up were more likely to observe a significant association between obesity and coronary artery disease (Bogers, 2007) . Nonetheless, our analysis, with a 10-year median follow-up, showed significantly higher mortality rates for all endpoints considered in individuals exposed to above normal BMI values, and particularly obesity. The use of Mendelian randomization methodology, in theory being less affected by bias or confounding, has the potential to establish a causal relationship between modifiable exposures and disease outcomes, compared to observational (non-genetic studies). This approach could help in understanding the complexity in the link between different grades of BMI and the endpoints analyzed.
Conclusion
Overweight and obesity significantly increased the risk of cancer death and of fatal and non-fatal cardiovascular disease in women; whereas obese men presented a significant higher risk of death from all causes and for cancer, specifically. Aging, diabetes, hypertension, and total cholesterol may act as effect modifiers in these associations.
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